Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.
Hoang NM, Liu Y, Bates PD, Heaton AR, Lopez AF, Liu P, Zhu F, Chen R, Kondapelli A, Zhang X, Selberg PE, Ngo VN, Skala MC, Capitini CM, Rui L.
Hoang NM, et al. Among authors: skala mc.
Cell Rep Med. 2024 Apr 16;5(4):101484. doi: 10.1016/j.xcrm.2024.101484. Epub 2024 Mar 29.
Cell Rep Med. 2024.
PMID: 38554704
Free PMC article.